Nov 12, 2019 / 10:00PM GMT
Erin Elizabeth Wilson Wright - Crédit Suisse AG - Research Division - Director & Senior Equity Research Analyst
Okay. Good afternoon, everybody. My name is Erin Wright. I cover life sciences tools, diagnostics at Credit Suisse.
We're happy to have Phibro Animal Health with us today. With them, we have CFO, Richard Johnson. Just as a reminder, Phibro is the leading manufacturer of livestock therapeutics across the animal health space, where we cover a bunch of different companies.
I guess I wanted to kick off -- and this is a fireside chat, so feel free to reach out or raise your hand if you do have a question or e-mail me if you would also like to submit a question for me to ask. I'm happy to do so.
I'll start off and kick it off kind of the most recent quarter. Can you give us an overview of the more recent trends you're seeing, an update on ASF and global dynamics across your different livestock segments?
Richard G. Johnson - Phibro Animal Health Corporation - CFO
Our most recent September quarter --
Phibro Animal Health Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot